What is the current valuation of the South Korea Biomarker Technologies Market?

As of 2024, the market valuation was 0.751 USD Billion. Read More

What is the projected market size for the South Korea Biomarker Technologies Market by 2035?

The market is projected to reach 1.75 USD Billion by 2035. Read More

What is the expected CAGR for the South Korea Biomarker Technologies Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 8.01%. Read More

Which application segment is anticipated to have the highest valuation in the South Korea Biomarker Technologies Market?

The Oncology application segment is expected to grow from 0.3 to 0.7 USD Billion. Read More

How does the Cardiology segment perform in terms of market valuation?

The Cardiology segment is projected to increase from 0.15 to 0.35 USD Billion. Read More

What are the key technologies driving the South Korea Biomarker Technologies Market?

Key technologies include Genomics, Proteomics, and Bioinformatics, with valuations ranging from 0.1 to 0.45 USD Billion. Read More

Which end-use segment is likely to dominate the market in the coming years?

Pharmaceutical Companies are expected to lead, with a valuation projected to rise from 0.3 to 0.7 USD Billion. Read More

What product type is forecasted to show significant growth in the market?

Reagents are anticipated to grow from 0.3 to 0.675 USD Billion. Read More

Who are the major players in the South Korea Biomarker Technologies Market?

Key players include Samsung Biologics, LG Chem, and Celltrion, among others. Read More

What trends are influencing the growth of the South Korea Biomarker Technologies Market?

The market growth is influenced by advancements in technology and increasing demand for personalized medicine. Read More

South Korea Biomarker Technologies Market

ID: MRFR/HC/54482-HCR

200 Pages

Vikita Thakur

Last Updated: May 12, 2026

South Korea Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035

South Korea Biomarker Technologies Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 South Korea Biomarker Technologies Market, BY Application (USD Billion) | |
  1. 4.1.1 Oncology | |
  2. 4.1.2 Cardiology | |
  3. 4.1.3 Neurology | |
  4. 4.1.4 Infectious Diseases | |
  5. 4.1.5 Metabolic Disorders |
2. 4.2 South Korea Biomarker Technologies Market, BY Technology (USD Billion) | |
  1. 4.2.1 Genomics | |
  2. 4.2.2 Proteomics | |
  3. 4.2.3 Metabolomics | |
  4. 4.2.4 Immunoassays | |
  5. 4.2.5 Bioinformatics |
3. 4.3 South Korea Biomarker Technologies Market, BY End Use (USD Billion) | |
  1. 4.3.1 Pharmaceutical Companies | |
  2. 4.3.2 Research Institutions | |
  3. 4.3.3 Diagnostic Laboratories | |
  4. 4.3.4 Contract Research Organizations |
4. 4.4 South Korea Biomarker Technologies Market, BY Product Type (USD Billion) | |
  1. 4.4.1 Reagents | |
  2. 4.4.2 Assays | |
  3. 4.4.3 Instruments | |
  4. 4.4.4 Software 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the South Korea Biomarker Technologies Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the South Korea Biomarker Technologies Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Samsung Biologics (KR) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 LG Chem (KR) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Celltrion (KR) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Hanmi Pharmaceutical (KR) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 SK Biopharmaceuticals (KR) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Genexine (KR) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Medytox (KR) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Korea United Pharm (KR) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Daewoong Pharmaceutical (KR) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
6. 6.3 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
7. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USE |
8. 6.5 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
9. 6.6 KEY BUYING CRITERIA OF SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET |
15. 6.12 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion) |
17. 6.14 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2024 (% SHARE) |
18. 6.15 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
19. 6.16 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY END USE, 2024 (% SHARE) |
20. 6.17 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY END USE, 2024 TO 2035 (USD Billion) |
21. 6.18 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2024 (% SHARE) |
22. 6.19 SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
  2. 7.2.2 BY TECHNOLOGY, 2026-2035 (USD Billion) | |
  3. 7.2.3 BY END USE, 2026-2035 (USD Billion) | |
  4. 7.2.4 BY PRODUCT TYPE, 2026-2035 (USD Billion) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

South Korea Biomarker Technologies Market Segmentation

South Korea Biomarker Technologies Market By Application (USD Billion, 2022-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Metabolic Disorders

South Korea Biomarker Technologies Market By Technology (USD Billion, 2022-2035)

Genomics
Proteomics
Metabolomics
Immunoassays
Bioinformatics

South Korea Biomarker Technologies Market By End Use (USD Billion, 2022-2035)

Pharmaceutical Companies
Research Institutions
Diagnostic Laboratories
Contract Research Organizations

South Korea Biomarker Technologies Market By Product Type (USD Billion, 2022-2035)

Reagents
Assays
Instruments
Software

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓